Back to Search
PRINZE MACK, M.D.
M.D.
Ophthalmology Physician
NPI: 1609990613IndividualAccepts Medicare
Specialties, Licenses & Credentials
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
25MA08221100(NJ)
CMS Specialties
PrimaryOPHTHALMOLOGY
Education
RUTGERS NEW JERSEY MEDICAL SCHOOL
Class of 2003
Research & Publications (20)
GCP, a genistein-rich compound, inhibits proliferation and induces apoptosis in lymphoma cell lines.
PMID 19394691·Leuk Res·2010
7-preclinical
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer.
PMID 19169683·Cancer Chemother Pharmacol·2009
3-trial
Hip dislocation and femoral neck fracture: decision-making for head preservation.
PMID 19616777·Injury·2009
5-case
Individualizing therapy for non-small-cell lung cancer: a paradigm shift from empiric to integrated decision-making.
PMID 19443333·Clin Lung Cancer·2009
8-other
Biomechanical Regulation of Endothelium-dependent Events Critical for Adaptive Remodeling.
PMID 19047056·J Biol Chem·2009
8-other
Beyond antiepidermal growth factor receptors and antiangiogenesis strategies for nonsmall cell lung cancer: exploring a new frontier.
PMID 19532012·Curr Opin Oncol·2009
6-review
A phase ii study of gemcitabine and capecitabine in patients with advanced renal cell cancer: Southwest Oncology Group Study S0312.
PMID 19487915·Am J Clin Oncol·2009
3-trial
Japanese-US common-arm analysis of paclitaxel plus carboplatin in advanced non-small-cell lung cancer: a model for assessing population-related pharmacogenomics.
PMID 19470925·J Clin Oncol·2009
8-other
Multidrug-resistant protein-3 gene regulation by the transcription factor Nrf2 in human bronchial epithelial and non-small-cell lung carcinoma.
PMID 19345732·Free Radic Biol Med·2009
8-other
Results of a phase I trial of 12 patients with locally advanced pancreatic carcinoma combining gefitinib, paclitaxel, and 3-dimensional conformal radiation: report of toxicity and evaluation of circulating K-ras as a potential biomarker of response to therapy.
PMID 19307945·Am J Clin Oncol·2009
3-trial
Direct bound on the total decay width of the top quark in pp collisions at sqrt[s]=1.96 TeV.
PMID 19257413·Phys Rev Lett·2009
8-other
Search for maximal flavor violating scalars in same-charge lepton pairs in pp collisions at sqrt[s]=1.96 TeV.
PMID 19257412·Phys Rev Lett·2009
8-other
The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells.
PMID 19240653·J Thorac Oncol·2009
8-other
Cell migration into scaffolds under co-culture conditions in a microfluidic platform.
PMID 19107284·Lab Chip·2009
7-preclinical
Measurement of the top-quark mass with dilepton events selected using neuroevolution at CDF.
PMID 19518620·Phys Rev Lett·2009
8-other
Serum osteopontin levels are highly prognostic for survival in advanced non-small cell lung cancer: results from JMTO LC 0004.
PMID 19620934·J Thorac Oncol·2009
8-other
Measurement of the single-top-quark production cross section at CDF.
PMID 19113697·Phys Rev Lett·2008
8-other
Search for the Higgs boson produced in association with Z-->l+l in pp collisions at sqrt[s]=1.96 TeV.
PMID 19113696·Phys Rev Lett·2008
8-other
Search for supersymmetry in pp collisions at sqrt[s]=1.96 TeV Using the trilepton signature for chargino-neutralino production.
PMID 19113694·Phys Rev Lett·2008
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 192 Jack Martin Blvd Unit B4
Brick, NJ 08724 - Phone
- (732) 835-2020
Quick Facts
- NPI
- 1609990613
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 23
- Publications
- 20
Are you this provider?
Claim Your Profile